p53-independent induction of p21(WAF1/CIP1) expression in pericentral hepatocytes following carbon tetrachloride intoxication

Cell Growth and Differentiation

Volumn 8, Issue 9, 1997, Pages 951-961

  Serfas, Michael S ^a   Goufman, Eugene ^a   Feuerman, Miriam H ^b   Gartel, Andrei L ^a   Tyner, Angela L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CARBON TETRACHLORIDE; PROTEIN P21; PROTEIN P53; RNA;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; INTOXICATION; LIVER CELL; LIVER REGENERATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARBON TETRACHLORIDE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION; LIVER; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0030987661     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Gumucio, J. J., and Chianale, J. Liver cell heterogeneity and liver function.In: I.M. Arias, W. B. Jakoby, and H. Popper (eds.), The Liver: Biology and Pathobiology, pp. 931-9471. New York: Raven Press, Ltd., 1988.
2. Steer, C. J. Liver regeneration. FASEB J., 9: 1396-1400, 1995.
3. Fausto, N. Hepatic regeneration. In: D Zakim and T. D. Boyer (eds.), Hepatology: A Textbook of Liver Disease, pp. 32-58. Philadelphia: W. B. Saunders Co., 1996.
4. Ponder, K. P. Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies. FASEB J., 10: 673-682, 1996.
5. Thorgeirsson, S. S. Hepatic stem cells in liver regeneration. FASEB J., 10: 1249-1256, 1996.
6. Slater, T. F. Free-radical mechanisms in tissue injury. Biochem. J., 222: 1-15, 1984.
7. Inoue, M., Protective mechanism against reactive oxygen species. In: I. Arias, J. Boyer, and N. Fausto (eds.), The Liver: Biology and Pathobiology, pp. 443-459. New York: Raven Press, Ltd., 1994.
8. Morrison, G. R., Brock, F. E., Karl, I. E., and Shank, R. E. Quantitative analysis of regenerating and degenerating areas within the lobule of the carbon tetrachloride-injured liver. Arch. Biochem. Biophys., 111: 448-460, 1965.
9. Buhler, R., Lindros, K. O., Nordling, A., Johansson, I., and Ingelman-Sundberg, M. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur. J. Biochem., 204: 407-412, 1992.
10. Traber, P. G., Maganto, P., Wojcik, E., Keren, D., and Gumucio, J. J. Induction of P-450IIB genes within the rat liver acinus is not dependent on the chemical inducer or on the acinar organization. J. Biol. Chem., 264: 10292-10298, 1989.
11. El-Deiry, W., Tokino, T., Velculescu, V., Levy, D., Parsons, R., Trent, J., Lin, D., Mercer, W., Kinzler, K., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
12. Harper, J. W., Adami, G., Wei, N., Keyomarsi, K., and Elledge, S. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
13. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
14. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
15. Jiang, H., Lin, J., Su, Z., Collart, F., Huberman, E., and Fisher, P. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
16. Gartel, A. L., Serfas, M. S., and Tyner, A. L. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med., 273: 137-148, 1996.
17. Wu. H., Wade, M., Krall, L., Grisham, J., Xiong, Y., and Van Dyke, T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev., 10: 245-260, 1996.
18. Rosser, B. G., and Gores, G. J. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology, 108: 252-275, 1995.
19. Dulic, V., Kaufman, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p53-dependent inhibition of cyclindependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76: 1013-1023, 1994.
20. Namba, H., Hara, T., Tukazaki, T., Migita, K., Ishikawa, N., lto, K., Nagataki, S., and Yamashita, S. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res., 55: 2075-2080, 1995.
21. Macleod, K., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
22. Gartel, A. L., Serfas, M. S., Gartel, M., Goufman, E., Wu, G. S., El-Deiry, W. S., and Tyner, A. L. p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelial and during differentiation of the Caco-2 intestinal cell line. Exp. Cell Res., 227: 171-181, 1996.
23. Connolly, K. M., and Bogdanffy, M. S. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2′-deoxyuridine. J. Histochem. Cytochem., 41: 1-6, 1993.
24. Mancini, R., Marucci, L., Benedetti, A., Jezequel, A. M., and Orlandi, F. Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody. Liver, 14: 57-64, 1994.
25. Melvin, J. B. The localization of mitotic figures in regenerating mouse liver. Anat. Rec., 160: 607-618, 1968.
26. Paulsen, J. E., and Reichelt, K. L. Mouse liver regeneration after carbon tetrachloride injury as test system for hepatic growth regulators. Virchows Arch. B Cell Pathol., 62: 173-177, 1992.
27. Goyette, M., Petropoulos, C. J., Shank, P. R., and Fausto, N. Expression of a cellular oncogene during liver regeneration. Science (Washington DC), 279: 510-512, 1983.
28. Herbst, H., Milani, S., Schuppan, D., and Stein, H. Temporal and spatial patterns of proto-oncogene expression at early stages of toxic liver injury in the rat. Lab. Invest., 65: 324-333, 1991.
29. Schmiedeberg, P., Biempica, L., and Czaja, M. Timing of protooncogene expression varies in toxin-induced liver regeneration. J. Cell Physiol., 154: 294-300, 1993.
30. Landschulz, W. H., Johnson, P. F., and McKnight, S. L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (Washington DC), 240: 1759-1764, 1988.
31. Sutherland, J. A., Cook, A., Bannister, A. J., and Kouzarides, T. Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev., 6: 1810-1819, 1992.
32. Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R., and Darlington, G. J. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev., 10: 804-815, 1996.
33. Hoyt, P. R., Wang, T. H., Henley, D. C., Yang, D. M., Chang, L. Y., and Yang, W. K. Carbon tetrachloride induction of rapid changes in liver nuclear protein factors capable of sequence-specific binding to regulatory elements in the long terminal repeat of polytropic-class endogenous murine leukemia virus-related proviruses. Mol. Carcinog., 8: 245-254, 1993.
34. Taub, R. Transcriptional control of liver regeneration. FASEB J., 10: 413-427, 1996.
35. Shim, J., Lee, H., Park, J., Kim, H., and Choi, E. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature (Lond.), 381: 804-807, 1996.
36. Albrecht, J. H., Meyer, A. H., and Hu, M. Y. Regulation of cyclindependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology, 25: 557-563, 1997.
37. Fausto, N., and Mead, J. E. Regulation of liver growth: protooncogenes and transforming growth factors. Lab. Invest., 60: 4-13, 1989.
38. Fausto, N. Growth factors in liver development, regeneration and carcinogenesis. Prog. Growth Factor. Res., 3: 219-234, 1991.
39. Fausto, N., and Webber, E. M. Control of liver growth. Crit. Rev. Eukaryot. Gene Exp., 3: 117-135, 1993.
40. Thompson, N. L., Mead, J. E., Braun, L., Goyette, M., Shank, P. R., and Fausto. N. Sequential protooncogene expression during rat liver regeneration. Cancer Res., 46: 3111-3117, 1986.
41. Alcorn, J. A., Feitelberg, S. P., and Brenner, D. A. Transient induction of c-jun during hepatic regeneration. Hepatology, 11: 909-915, 1990.
42. Morello, D., Fitzgerald, M. J., Babinet, C., and Fausto, N. c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H-2K/ c-myc transgenic mice. Mol. Cell. Biol., 10: 3185-3193, 1990.
43. Columbano, A., Ledda-Columbano, G. M., Pibiri, M., Piga, R., Shinozuka, H., De Luca, V., Cerignoli, F., and Tripodi, M. Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene, 14: 857-863, 1997.
44. Czaja, M., Flanders, K., Biempica. L., Klein, C., Zern, M., and Weiner, F. Expression of tumor necrosis factor alpha and transforming growth factor beta 1 in acute liver injury. Growth Factors, 1: 219-226, 1989.
45. Diehl, A. M., Yin, M., Fleckenstein, J., Yang, S. Q., Lin, H. Z., Brenner, D. A., Westwick, J., Bagby, G., and Nelson, S. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am. J. Physiol., 267: G552-G561, 1994.
46. Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., and Diehl, A. M. Antibodies to tumor necrosis factor alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol., 263: G579-G585, 1992.
47. Shiohara, M., Akashi, M., Gombart, A., Yang, R., and Koeffler, H. Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J. Cell. Physiol., 166: 568-576, 1996.
48. Yakovlev, A., and Faden, A. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental injury. Mol. Chem. Neuropathy, 23: 179-190, 1994.
49. Monticello, T. M., Barton, D., Ma, X., Babish, J. G., and Durham, S. K. Comparison of acute hepatocellular proliferating cell nuclear antigen labeling indices and growth fractions, p34cdc2 kinases, and serum enzymes in carbon tetrachloride-treated rats. Toxicol. Pathol., 23: 439-446, 1995.
50. Flodby, P., Barlow, C., Kylefjord, H., Ahrlund-Richter, L., and Xanthopoulos, K. G. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha. J. Biol. Chem., 271: 24753-24760, 1996.
51. Diehl, A. M., Johns, D. C., Yang, S., Lin, H., Yin, M., Matelis, L. A., and Lawrence, J. H. Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes. J. Biol. Chem., 271: 7343-7350, 1996.
52. Deng, C., Zhang, P., Harper, J., Elledge, S., and Leder. P. Mice lacking p21 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.
53. Brugarolas, J., Chadrasekaran, C., Gordon, J., Beach, D., Jacks, T., and Hannon, G. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
54. Chirgwin, J. M., Przybyla, A. L., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
55. Siyanova, E. Y., Serfas, M. S., Mazo, I. A., and Tyner, A. L. Tyrosine kinase gene expression in the mouse small intestine. Oncogene, 9: 2053-2057, 1994.
56. Lau, L. F., and Nathan, D. Expression of a set of growth-regulated immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos orc-myc. Proc. Natl. Acad. Sci. USA, 84: 1182-1186, 1987.
57. Foley, K., Leonard, M., and Engel, J. Quantitation of RNA using the polymerase chain reaction. Trends Genet., 9: 380-385, 1993.
58. El-Deiry, W. S., Tokino, T., Waldman, T., Velculescu, V., Oliner, J. D., Burell, M., Hill, D. E.. Rees, J. L., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Topological control of p21 (WAF1) expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
59. Gilman, M., Ribonuclease protection assay. In: F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith. J. G. Seidman, and K. Struhl (eds.), Protocols in Molecular Biology, pp. 4.7.1-4.7.8. New York: Wiley Interscience, 1987.